SEPHIENCE
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SEPHIENCE, covering 2025-07-28 to 2026-02-11. Get the full timeline:
Most recent: EMA Authorised: Sephience (sepiapterin) — PTC Therapeutics International Limited